Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $17.20.
Several research analysts recently issued reports on SENS shares. HC Wainwright cut their price objective on Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, May 12th. Weiss Ratings cut Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 28th. Mizuho dropped their price target on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, July 15th. Finally, Stifel Nicolaus dropped their price target on Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Monday, May 11th.
Read Our Latest Report on SENS
Insider Activity
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. First Light Asset Management LLC boosted its stake in shares of Senseonics Holdings, Inc. Common Stock by 666.7% during the 2nd quarter. First Light Asset Management LLC now owns 35,708,124 shares of the company’s stock worth $17,011,000 after purchasing an additional 31,050,619 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Senseonics Holdings, Inc. Common Stock by 2.2% during the third quarter. Vanguard Group Inc. now owns 34,219,484 shares of the company’s stock worth $14,920,000 after buying an additional 749,453 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Senseonics Holdings, Inc. Common Stock by 26.6% in the second quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company’s stock valued at $4,147,000 after buying an additional 1,828,302 shares during the last quarter. Masters Capital Management LLC raised its position in shares of Senseonics Holdings, Inc. Common Stock by 11.1% in the third quarter. Masters Capital Management LLC now owns 5,000,000 shares of the company’s stock valued at $2,179,000 after buying an additional 500,000 shares during the last quarter. Finally, UBS Group AG lifted its stake in shares of Senseonics Holdings, Inc. Common Stock by 409.0% during the third quarter. UBS Group AG now owns 4,248,519 shares of the company’s stock valued at $1,852,000 after buying an additional 3,413,866 shares during the period. 12.36% of the stock is currently owned by hedge funds and other institutional investors.
Senseonics Holdings, Inc. Common Stock Trading Down 0.2%
NASDAQ:SENS opened at $4.86 on Friday. The company has a debt-to-equity ratio of 1.05, a current ratio of 3.51 and a quick ratio of 3.19. The stock has a market cap of $203.16 million, a P/E ratio of -2.43 and a beta of 0.99. The company’s 50-day simple moving average is $6.03. Senseonics Holdings, Inc. Common Stock has a twelve month low of $4.79 and a twelve month high of $11.60.
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.71) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.65) by ($0.06). The business had revenue of $11.71 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 213.87% and a negative return on equity of 129.97%. On average, equities research analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.38 earnings per share for the current year.
Senseonics Holdings, Inc. Common Stock Company Profile
Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.
Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.
Featured Stories
- Five stocks we like better than Senseonics Holdings, Inc. Common Stock
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Senseonics Holdings Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
